This month, the HIV Vaccine Trials Network is reintroducing the HVTNews. The publication will highlight the progress of this international collaboration of scientists and educators who are searching for an effective and safe HIV vaccine.
"In this and future editions, we will clarify why HIV vaccine research in humans provides critical momentum for the discovery and development of effective vaccines," said Dr. Jim Kublin, executive director.
Access a pdf of the new HVTN publication here. The publication will also be available under "What’s new on Center websites" section of the Center News Weekly home page.
In addition to highlights from recent HVTN publications, and announcements of upcoming meetings and conferences, this edition of the newsletter features the following articles:
Headquartered at the Hutchinson Center, the Network’s HIV Vaccine Trial Units are located at leading research institutions in 27 cities on four continents and led by internationally renowned HIV vaccine and prevention investigators.